Beelen; Andrew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Beelen; Andrew.The latest application filed is for "treatment of cancers having driving oncogenic mutations".
- Beelen; Andrew - Research Triangle Park NC
| Patent | Date |
|---|---|
| Treatment of EGFR-driven cancer with fewer side effects Grant 11,395,821 - Sorrentino , et al. July 26, 2 | 2022-07-26 |
| G1T38 superior dosage regimes Grant 11,357,779 - Beelen , et al. June 14, 2 | 2022-06-14 |
| Treatment Of Cancers Having Driving Oncogenic Mutations App 20210030758 - Strum; Jay Copeland ; et al. | 2021-02-04 |
| G1t38 Superior Dosage Regimes App 20200405721 - Beelen; Andrew ; et al. | 2020-12-31 |
| Treatment Of Egfr-driven Cancer With Fewer Side Effects App 20190374545 - Sorrentino; Jessica A. ; et al. | 2019-12-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 